Sort
17,828 grants matching “crispr”
Retrotransposon derived promoters drive alternative host gene isoforms with important developmental functions
$555,823Lin He · University Of California Berkeley · R01 · FY2023 · HD
Retrotransposon derived promoters drive alternative host gene isoforms with important developmental functions
$555,823Lin He · University Of California Berkeley · R01 · FY2022 · HD
Identification of genes related to spcific properties of mammalian cells
$555,692Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Molecular characterization of a novel cause of human FSGS
$555,633Alda Tufro · Yale University · R01 · FY2017 · DK
Connecting 3D genome misfolding to transcriptional silencing in fragile X syndrome
$555,605Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · R37 · FY2025 · MH
The RATIOS Study: Risk/benefit AssessmenT by IRB review of Phase One Studies
$555,553Mark Yarborough · University Of California At Davis · R01 · FY2023 · NS
Zfp423 Mechanisms in Joubert Syndrome and Related Disorders
$555,517Bruce A Hamilton · University Of California, San Diego · R01 · FY2023 · NS
Mapping the Pharmacogenetic Landscape for Precision Medicine
$555,492Alan Ashworth · University Of California, San Francisco · U54 · FY2018 · CA
Genetics and Pathobiology of Cutaneous Mosaic Disorders
$555,343Keith A Choate · Yale University · R01 · FY2022 · AR
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$555,144Joseph C Wu · Stanford University · R01 · FY2018 · HL
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
$555,102Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
$554,891Keith D Robertson · Mayo Clinic Rochester · R01 · FY2023 · CA
Engineering viral-specific T cells with improved function and persistence
$554,648E. John Wherry · University Of Pennsylvania · P01 · FY2025 · AI
RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity
$554,623Patrick Andries Murphy · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · HL
Integration and functionality of retinal organoid transplants
$554,601Magdalene J Seiler · University Of California-Irvine · R01 · FY2025 · EY
MYB family alterations in pediatric gliomas
$554,504Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2017 · CA
MYB family alterations in pediatric gliomas
$554,504Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2020 · CA
MYB family alterations in pediatric gliomas
$554,504Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2018 · CA
MYB family alterations in pediatric gliomas
$554,504Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Multiomic profiling of cell types mediating opioid use disorder in rats
$554,504Francesca Telese · University Of California, San Diego · R01 · FY2022 · DA
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY
$554,460Shannon Elizabeth Boye · University Of Florida · R01 · FY2020 · EY
Mobile Group II Introns and Their Reverse Transcriptases
$554,414Alan M. Lambowitz · University Of Texas At Austin · R01 · FY2016 · GM
A Systems Approach to Mapping the DNA Damage Response
$554,409Trey Ideker · University Of California, San Diego · R01 · FY2021 · ES
Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis
$554,401Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2022 · NS
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
$554,253Daniel H Geschwind · Icahn School Of Medicine At Mount Sinai · U54 · FY2023 · NS